arrow
M

Michael J. Zeléfsky

Department of Radiation Oncology
H指数:109
被引数:4.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluating indeterminate bone lesions and lymph nodes on PSMA-PET: a multidisciplinary consensus algorithm and 1-year implementation results

评估PSMA-PET上不确定的骨病变和淋巴结:一个多学科共识算法及1年实施结果

2026-01-060
PRE
Feasibility of combining high-dose-rate prostate brachytherapy with dose intensification to the MRI dominant lesion followed by real-time adaptive MR-guided pelvic radiotherapy for high-risk prostate cancer

将高剂量率前列腺近距离治疗与对MRI优势病灶进行剂量强化,随后进行实时自适应MR引导盆腔放疗用于高危前列腺癌的可行性

2026-01-010
PRE
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer

表征全人群基因组风险分布,以开发用于临床局部前列腺癌患者预后判断的新型临床-基因组风险系统

2025-12-090
OA
Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer

使用立体定向放射治疗低或中危前列腺癌患者的1期剂量递增研究的长期结果

2024-08-010
PRE
Development of Prostate Bed Delineation Consensus Guidelines for Magnetic Resonance Image-Guided Radiotherapy and Assessment of Its Effect on Interobserver Variability
2024-02-013
PRE
Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer

[177Lu]Lu-PSMA-617放射性药物联合立体定向放疗治疗寡转移去势敏感型前列腺癌的病灶剂量学

2023-08-314
OA
Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study
2023-07-0110
PRE
Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel
2023-03-015
PRE